Reconsidering Pediatric Hearing Assessment: An Interview with Angela Bonino, PhD
Angela Bonino, PhD, discusses her research on the lack of access to adequate hearing assessments for children with developmental disabilities.
Angela Bonino, PhD, discusses her research on the lack of access to adequate hearing assessments for children with developmental disabilities.
In laboratory studies, BPN14770 promoted the maturation of connections between neurons, (which is impaired in patients with fragile X syndrome). BPN14770 is being developed by Tetra Therapeutics for the treatment of fragile X syndrome.
The study is said to have demonstrated that the cord blood infusions were safe, feasible, and well-tolerated. In addition, 45% of participants showed improvements on Auditory Brainstem Response (ABR) after their infusion.
A researcher at Seattle Children’s Hospital and Research Institute has found a genetic identifier for autism that includes physical features.
Read More